rs149580171

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_032575.3(GLIS2):​c.1464G>A​(p.Leu488Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000755 in 1,588,886 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0043 ( 4 hom., cov: 33)
Exomes 𝑓: 0.00038 ( 4 hom. )

Consequence

GLIS2
NM_032575.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.402

Publications

0 publications found
Variant links:
Genes affected
GLIS2 (HGNC:29450): (GLIS family zinc finger 2) This gene is a member of the GLI-similar zinc finger protein family and encodes a nuclear transcription factor with five C2H2-type zinc finger domains. The protein encoded by this gene is widely expressed at low levels in the neural tube and peripheral nervous system and likely promotes neuronal differentiation. It is abundantly expressed in the kidney and may have a role in the regulation of kidney morphogenesis. p120 regulates the expression level of this protein and induces the cleavage of this protein's C-terminal zinc finger domain. This protein also promotes the nuclear translocation of p120. Mutations in this gene cause nephronophthisis (NPHP), an autosomal recessive kidney disease characterized by tubular basement membrane disruption, interstitial lymphohistiocytic cell infiltration, and development of cysts at the corticomedullary border of the kidneys.[provided by RefSeq, Jan 2010]
PAM16 (HGNC:29679): (presequence translocase associated motor 16) This gene encodes a mitochondrial protein involved in granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling. This protein also plays a role in the import of nuclear-encoded mitochondrial proteins into the mitochondrial matrix and may be important in reactive oxygen species (ROS) homeostasis. Mutations in this gene cause Megarbane-Dagher-Melike type spondylometaphyseal dysplasia, an early lethal skeletal dysplasia characterized by short stature, developmental delay and other skeletal abnormalities. [provided by RefSeq, May 2017]
PAM16 Gene-Disease associations (from GenCC):
  • autosomal recessive spondylometaphyseal dysplasia, Megarbane type
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 16-4337413-G-A is Benign according to our data. Variant chr16-4337413-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 462720.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.402 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLIS2NM_032575.3 linkc.1464G>A p.Leu488Leu synonymous_variant Exon 7 of 7 ENST00000433375.2 NP_115964.2 Q9BZE0
GLIS2NM_001318918.2 linkc.1464G>A p.Leu488Leu synonymous_variant Exon 8 of 8 NP_001305847.1 Q9BZE0B3KTH4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLIS2ENST00000433375.2 linkc.1464G>A p.Leu488Leu synonymous_variant Exon 7 of 7 1 NM_032575.3 ENSP00000395547.1 Q9BZE0
GLIS2ENST00000262366.7 linkc.1464G>A p.Leu488Leu synonymous_variant Exon 8 of 8 2 ENSP00000262366.3 Q9BZE0
ENSG00000262712ENST00000574705.1 linkn.406C>T non_coding_transcript_exon_variant Exon 1 of 1 6
PAM16ENST00000577031.5 linkc.291+3507C>T intron_variant Intron 4 of 4 4 ENSP00000459113.1 I3L1U7

Frequencies

GnomAD3 genomes
AF:
0.00421
AC:
641
AN:
152156
Hom.:
4
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0147
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00137
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.000956
AC:
194
AN:
203016
AF XY:
0.000621
show subpopulations
Gnomad AFR exome
AF:
0.0146
Gnomad AMR exome
AF:
0.000543
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000114
Gnomad OTH exome
AF:
0.000386
GnomAD4 exome
AF:
0.000384
AC:
552
AN:
1436612
Hom.:
4
Cov.:
34
AF XY:
0.000337
AC XY:
240
AN XY:
712860
show subpopulations
African (AFR)
AF:
0.0142
AC:
470
AN:
33016
American (AMR)
AF:
0.000685
AC:
29
AN:
42350
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25624
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38604
South Asian (SAS)
AF:
0.0000846
AC:
7
AN:
82720
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47742
Middle Eastern (MID)
AF:
0.000348
AC:
2
AN:
5748
European-Non Finnish (NFE)
AF:
0.00000636
AC:
7
AN:
1101348
Other (OTH)
AF:
0.000622
AC:
37
AN:
59460
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
37
74
110
147
184
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00426
AC:
648
AN:
152274
Hom.:
4
Cov.:
33
AF XY:
0.00426
AC XY:
317
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0148
AC:
616
AN:
41556
American (AMR)
AF:
0.00137
AC:
21
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68008
Other (OTH)
AF:
0.00521
AC:
11
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
30
61
91
122
152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00114
Hom.:
0
Bravo
AF:
0.00447
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Aug 29, 2022
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Kidney disorder Benign:1
Jun 01, 2018
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nephronophthisis Benign:1
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nephronophthisis 7 Benign:1
Jul 19, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
11
DANN
Benign
0.90
PhyloP100
0.40
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149580171; hg19: chr16-4387414; API